Equities Analysts Set Expectations for ADIL Q1 Earnings
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Free Report) – Investment analysts at Litchfield Hills Research upped their Q1 2025 earnings per share (EPS) estimates for Adial Pharmaceuticals in a report issued on Tuesday, March 18th. Litchfield Hills Research analyst T. O’neill now anticipates that the company will earn ($0.37) per share for the quarter, up from […]
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL – Free Report) – Investment analysts at Litchfield Hills Research upped their Q1 2025 earnings per share (EPS) estimates for Adial Pharmaceuticals in a report issued on Tuesday, March 18th. Litchfield Hills Research analyst T. O’neill now anticipates that the company will earn ($0.37) per share for the quarter, up from […]
